NFKB1 and Huntington disease: The activated NF-κB pathway is evident in the neurons of the hippocampus and entorhinal cortex of post-mortem brain samples from patients with AD [365,366], in the dopaminergic neurons within the SNPc of post-mortem brain samples from patients with PD [367], and in peripheral immune cells of patients with HD [368].